Monteiro, RicardoBaiula, MónicaSantos, MarleneSpampinato, Santi2021-11-242021-11-242021Monteiro, R., Baiula, M., Santos, M., & Spampinato, S. (2021). FOXO3-REST Axis: a Therapeutic Target for Medulloblastoma? 15th YES Meetinghttp://hdl.handle.net/10400.22/18942Medulloblastoma has poor outcome due also to adverse events caused by the treatment [1]. An improved anti-tumor strategy is needed to enhance patient survival rate. REST is a transcription factor overexpressed in medulloblastoma cells and it’s associated with the formation of this brain tumor and the low survival rate, suggesting an oncogenic role [2][3].engMedulloblastomaAnti-tumor strategyconference object10.1097/j.pbj.0000000000000100